$ETON's ET-600 is highlighted in upcoming FDA PDUFA calendars, with a focus on central diabetes insipidus. Social media buzz around biotech catalysts is increasing, with significant engagement on posts detailing PDUFA dates and potential approvals.
$ETON refers to a specific cryptocurrency or digital asset.
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [-----] +1,046%
[--] Month: [-------] +220%
[--] Months: [-------] -43%
[--] Year: [---------] +195%
1-Year High: [-------] on 2025-08-07
1-Year Low: [--] on 2026-01-17
Engagements by network (24h): X: [-----] Reddit: [--]
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2026-01-27
Mentions by network (24h): X: [--] Reddit: [--]
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $eton in the last [--] hours which is up 11% from [--] in the previous [--] hours
Daily Average: [--]
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2026-01-27
The most influential creators that mention $eton in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Biopharma_Watch | [--] | [-----] | [--] | [---] |
| @fastmoneysource | [--] | [---] | [--] | [--] |
| @Biotechmaster12 | [--] | [-----] | [--] | [--] |
| @TheShortSqueezy | [--] | [---] | [--] | [--] |
Sentiment 24-Hour Time-Series Raw Data
Current Value: 80%
Daily Average: 93%
[--] Month: 100% +25%
[--] Months: 100% no change
[--] Year: 100% no change
1-Year High: 100% on 2025-02-17
1-Year Low: 33% on 2025-08-09
Most Supportive Themes:
Most Critical Themes:
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"Biotech Stock Catalyst Watchlist for Q1 [----] Probability of approval score card is below $ETON PDUFA $OCUL Phase [--] $TARA Phase [--] $REGN BLA $ASND PDUFA $XOMA Phase [--] $GOSS Phase [--] $CAPR BLA $RLAY Phase 1/2 $RYTM PDUFA $TELO Pre-clinical $RCKT PDUFA $LNTH PDUFA $ABVX Phase [--] $ALMS Phase [--] $MGX Preclinical $CTNM Phase 1b $SXTP Phase [--] $NAYA Phase 1/2a $ACAD Phase [--] https://twitter.com/i/web/status/2022341817685975187 https://twitter.com/i/web/status/2022341817685975187"
X Link @Biopharma_Watch 2026-02-13T16:07Z [----] followers, [----] engagements
"February Biotech PDUFA Pulse: 📡 Whats on the FDA Radar Feb [--] $RGNX RGX-121 (MPS II / Hunter syndrome) Priority Review Feb [--] $MRK Keytruda (platinum-resistant recurrent ovarian cancer) Priority Review (label expansion) Feb [--] $VNDA Bysanti (bipolar I disorder / schizophrenia) Feb [--] $ETON ET-600 (central diabetes insipidus) Feb [--] $ASND TransCon CNP (achondroplasia) Priority Review Feb [--] $BMRN PALYNZIQ (PKU adolescents) Priority Review (label expansion) See the attached graphic for the full February PDUFA calendar. https://twitter.com/i/web/status/2016215337554083884"
X Link @BiopharmIQ 2026-01-27T18:22Z 28.9K followers, 105.9K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing